According to MannKind Corp's latest financial reports the company's total liabilities are $0.72 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.72 B | 32.16% |
2022-12-31 | $0.54 B | 2.89% |
2021-12-31 | $0.53 B | 83.55% |
2020-12-31 | $0.28 B | 1.68% |
2019-12-31 | $0.28 B | 0.52% |
2018-12-31 | $0.28 B | -5.52% |
2017-12-31 | $0.29 B | 2.98% |
2016-12-31 | $0.29 B | -39.03% |
2015-12-31 | $0.47 B | 1.82% |
2014-12-31 | $0.46 B | 61.81% |
2013-12-31 | $0.28 B | -20.07% |
2012-12-31 | $0.36 B | -29.46% |
2011-12-31 | $0.51 B | 10.89% |
2010-12-31 | $0.46 B | 50.93% |
2009-12-31 | $0.30 B | 56.66% |
2008-12-31 | $0.19 B | 9.13% |
2007-12-31 | $0.17 B | 14.78% |
2006-12-31 | $0.15 B | 630.34% |
2005-12-31 | $21.39 M | 63.06% |
2004-12-31 | $13.12 M | -8.25% |
2003-12-31 | $14.29 M | 2.14% |
2002-12-31 | $14 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 18,921.27% | ๐บ๐ธ USA |
Novo Nordisk NVO | $30.79 B | 4,168.87% | ๐ฉ๐ฐ Denmark |
Eli Lilly LLY | $53.14 B | 7,266.94% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 9,470.73% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.64 B | 128.66% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.26 B | -62.98% | ๐บ๐ธ USA |